{"status":"OK","data":{"advertisement":{"id":261620,"title":"Zapytanie ofertowe 13 09 2024 A","partial_offer_allowed":false,"publication_date":"2024-09-13","submission_deadline":"2024-09-20 23:59:59","planned_sign_date":"2024-09-01","supplementary_orders":"Zgodnie z tre\u015bci\u0105 zapytania ofertowego.","terms_of_contract_change":"Zgodnie z tre\u015bci\u0105 zapytania ofertowego.","created_at":"2024-09-13 15:55:17","modified_at":"2024-09-21 00:00:20","contact_persons":[{"id":58,"forename":"Anna","surname":"Dziedzicka","phone_number":"+48 538 512 756","email":"vendors.clinical@ryvu.com","created_by":null,"created_at":"2025-07-31 13:43:16","modified_at":"2025-07-31 13:43:16","modified_by":null}],"orders":[{"id":424216,"estimated_value":null,"order_items":[{"id":478246,"description":"Transporter Inhibition Panel\nIn-vitro cell-based functional assays to evaluate test compounds for its inhibitory (Antagonist) potential towards selected human drug transporters. Each drug transporter inhibition activity must be evaluated using specific transporter substrates. Concentration of substrate used during evaluation should be equal or less than Km value (validated and established by testing laboratory). Each test compound to be evaluated at single concentration with minimum n=2 replicates, assay mode is flexible.\n\nList of human drug transporters to be evaluated:\n1. P-pg (Class- ABC)\n2. BCRP (Class- ABC)\n3. OATP1B1 (Class- SLC)\n4. OATP1B3 (Class- SLC)\n5. OAT1 (Class- SLC)\n6. OAT3 (Class- SLC)\n7. OCT1 (Class-SLC)\n8. OCT2 (Class- SLC)\n9. MRP2 (Class- ABC)\n10. MATE1 (Class- SLC)\n11. MATE2K (Class- SLC)\n12. BSEP (Class- ABC)","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-13 15:55:17","modified_by":null,"id":537943,"type":{"id":1,"name":"adres"},"group_uuid":"fab9ec25-5697-4d0d-bc97-58d4e2136366"}],"participation_conditions":[{"id":1319058,"description":"Szczeg\u00f3\u0142owe warunki umieszczono w tre\u015bci zapytania ofertowego nr 13 09 2024 A","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-13 15:55:17","modified_by":null,"group_uuid":"c4662d32-e146-4162-be5f-d89b05a270b0"},{"id":1319059,"description":"Uzupe\u0142niony Formularz ofertowy do zapytania ofertowego 13 09 2024 A","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-13 15:55:17","modified_by":null,"group_uuid":"e5c82dd3-80f8-427f-8e48-f50e207a8a98"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-13 15:55:17","modified_by":null,"group_uuid":"fcde2b43-2fde-45fa-85eb-0fa06ecc5a7b"}],"evaluation_criteria":[{"id":734856,"price_criterion":true,"description":"Cena 100%","created_by":null,"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-13 15:55:17","modified_by":null,"group_uuid":"e6a459ec-d8b8-4309-b5a5-d26fc10b4674"}],"is_variant":false,"title":"Transporter Inhibition Panel","order_node":{"id":321286},"created_by":null,"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-13 15:55:17","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":708906,"street":"Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-13 15:55:17","modified_by":{"id":112,"contact_persons":[]},"id":262205},"advertisement":{"id":198639,"number":"2024-112-198639","publication_date":"2024-09-13","created_by":{"id":112,"contact_persons":[]},"created_at":"2024-09-13 15:55:17","modified_at":"2024-09-21 00:00:20","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[261620],"enrollment":{"id":39917,"name":"Rozw\u00f3j celowanej terapii przeciwnowotworowej opartej o zahamowanie helikazy WRN (CanSL)","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-07-17 12:04:06","modified_at":"2023-07-17 12:04:06","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":261620,"publication_date":"2024-09-13"},"id":1427940,"name":"RFQ 13 09 2024 A","file":{"id":1591482,"name":"RFQ 13 09 2024 A.pdf","created_at":"2024-09-13 15:51:34","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1591482"},"group_uuid":"ea804565-8167-4971-b20e-d2caa7fafc58"},{"origin":{"id":261620,"publication_date":"2024-09-13"},"id":1427941,"name":"Offer form to RFQ 13 09 2024 A (Appendix 1)","file":{"id":1591489,"name":"Offer form to RFQ 13 09 2024 A (Appendox 1).docx","created_at":"2024-09-13 15:53:11","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1591489"},"group_uuid":"e623096d-7e89-4d16-811e-977812f34dc3"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}